Showing results (131-140 of 169) with videos related to

Sort By:
Pageof 17
American Heart Journal|July 15, 2006
Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programAnique Ducharme, Karl Swedberg, Marc A Pfeffer, et al.
Seminars in Thoracic and Cardiovascular Surgery|January 4, 2017
Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection FractionFred A Weaver, William T Abraham, William C Little, et al.
International Journal of Cardiology|April 30, 2018
Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery diseaseMarcel Halbach, William T Abraham, Christian Butter, et al.
Journal of the American College of Cardiology|February 7, 2024
Implantable Hemodynamic Monitors Improve Survival in Patients With Heart Failure and Reduced Ejection FractionJoAnn Lindenfeld, Maria Rosa Costanzo, Michael R Zile, et al.
The American Journal of Cardiology|November 5, 2022
Growth Differentiation Factor-15 as a Predictor of Functional Capacity, Frailty, and Ventricular Dysfunction in Patients With Aortic Stenosis and Preserved Left Ventricular Ejection FractionLauren Basmadjian, Nadia Bouabdallaoui, François Simard, et al.
CJC Open|June 22, 2026
Erratum: Author Correction to "Vaccination in Patients With Cardiovascular Disease: A Case-based Approach and Contemporary Review [Canadian Journal of Cardiology Open. Volume 7, Issue 10 (2025), 1375-1388]"Phelopater Sedrak, Vera Dounaevskaia, G B John Mancini, et al.
JACC. Heart Failure|December 1, 2022
Hemodynamically-Guided Management of Heart Failure Across the Ejection Fraction Spectrum: The GUIDE-HF TrialMichael R Zile, Mandeep R Mehra, Anique Ducharme, et al.
CJC Open|November 29, 2022
Association Between Right Ventricular Dysfunction and Adverse Outcomes in Peripartum Cardiomyopathy: Insights From the BRO-HF Quebec Cohort StudyChristine Pacheco, Maxime Tremblay-Gravel, Guillaume Marquis-Gravel, et al.
International Journal of Cardiology|September 29, 2022
Optimization of pharmacotherapies for ambulatory patients with heart failure and reduced ejection fraction is associated with improved outcomesMarilyne Jarjour, Jacinthe Leclerc, Nadia Bouabdallaoui, et al.
American Heart Journal|August 12, 2018
A comparison of the effects of selective and non-selective mineralocorticoid antagonism on glucose homeostasis of heart failure patients with glucose intolerance or type II diabetes: A randomized controlled double-blind trialSandra Korol, Michel White, Eileen O'Meara, et al.
Pageof 17